Publikation

Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS).

Wissenschaftlicher Artikel/Review - 26.04.2024

PubMed
DOI
Kontakt

Zitation
Couchepin J, Reinhold I, Kronig I, Guidi M, Buclin T, Schreiber P, Neofytos D, Lamoth F, Fungal Infection Network of Switzerland (FUNGINOS). Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS). Open Forum Infect Dis 2024; 11:ofae223.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Open Forum Infect Dis 2024; 11
Veröffentlichungsdatum
26.04.2024
ISSN (Druck)
2328-8957
Seiten
ofae223
Kurzbeschreibung/Zielsetzung

This analysis of 116 isavuconazole therapy courses shows that hepatic test disturbances (HTDs) were relatively frequent (29% of cases) but rarely led to treatment interruption (5%). Importantly, patients with baseline HTDs, including those attributed to a first-line triazole, did not exhibit a higher risk of subsequent HTD under isavuconazole therapy.